PAVmed owners report 14.3% stake

PAVmed Inc. reports that Tasso Partners, LLC and Dana Carrera beneficially own 912,996 and 914,246 shares respectively, representing 14.3% of outstanding common stock.

Accepted by SEC EDGAR 04/03/2026 - 04:46 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

PAVmed Inc. reports that Tasso Partners, LLC and Dana Carrera beneficially own 912,996 and 914,246 shares respectively, representing 14.3% of outstanding common stock. The percentage is calculated using 6,383,089 shares outstanding as of March 27, 2026, per the annual report on Form 10-K.

The filing states Ms. Carrera controls Tasso Partners through Tasso Capital, LLC and that the Reporting Persons filed this Amendment No. 1 jointly under a Joint Filing Agreement.

Insights

Corporate Governance Analyst

Joint ownership filing clarifies control and voting power.

The filing documents beneficial ownership and control: Tasso Partners holds 912,996 shares with sole voting and dispositive power, and Dana Carrera is attributed indirect ownership through control of Tasso Capital, LLC. The percentage uses a company-provided outstanding share count as of March 27, 2026.

Watch subsequent filings for any change in holdings or additional disclosures about agreements among reportingpersons; timing not specified in the excerpt.

Equity Capital Markets Analyst

Stake size may be meaningful to shareholders; filing is informational.

The reported 14.3% stake is large enough to be visible to the market but the filing contains no transaction details or proposed actions. It confirms sole voting and dispositive authority for the listed shares.

Future amendments or Schedule 13D would be required to show activist intent or plans; none are disclosed here.

Key Figures

Shares beneficially owned (Tasso Partners): 912,996 shares Shares attributed (Dana Carrera): 914,246 shares Percent of class: 14.3% +2 more

5 metrics

Shares beneficially owned (Tasso Partners) 912,996 shares Amount beneficially owned reported in amendment

Shares attributed (Dana Carrera) 914,246 shares Includes shares held by Tasso Partners plus 1,250 additional shares

Percent of class 14.3% Calculated using outstanding shares as of March 27, 2026

Shares outstanding 6,383,089 shares Outstanding shares used to calculate percentage as of March 27, 2026

Sole voting/dispositive power 912,996 / 914,246 shares Sole voting/dispositive power listed for Tasso Partners and Ms. Carrera

Key Terms

beneficially own, Schedule 13G/A, Joint Filing Agreement

3 terms

beneficially own regulatory

"Amount beneficially owned: Tasso Partners beneficially owns 912,996 shares"

Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

Schedule 13G/A regulatory

"(Amendment No. 1 ) PAVmed Inc. Common Stock"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Joint Filing Agreement regulatory

"Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 99.1"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake do Tasso Partners and Dana Carrera report in PAVM?

Tasso Partners reports 912,996 shares; Dana Carrera is attributed 914,246 shares. The filing states these holdings represent 14.3% of common stock based on 6,383,089 shares outstanding as of March 27, 2026.

Does this Schedule 13G/A indicate control by Dana Carrera at PAVM?

Yes. The filing states Ms. Carrera controls Tasso Capital, LLC, which controls Tasso Partners, and she may be deemed to beneficially own the shares held by Tasso Partners, per the joint filing disclosure.

What voting and dispositive power are reported for these holdings?

The filing reports sole voting and sole dispositive power. It lists 912,996 shares with sole voting and dispositive power for Tasso Partners and 914,246 shares with sole power for Ms. Carrera.

What share count is used to calculate the 14.3% figure for PAVM?

The percentage is calculated using 6,383,089 shares outstanding. That outstanding share count is cited as of March 27, 2026 and drawn from the company’s Form 10-K filed the same date.

Does this amendment disclose any purchases or sales by the reporting persons?

No transaction details are disclosed. The amendment updates beneficial ownership and control relationships but does not describe recent purchases, sales, or plans to buy or sell shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

PAVmed Inc.

(Name of Issuer)

Common Stock, Par Value $0.001 Per Share

(Title of Class of Securities)

70387R502

(CUSIP Number)

03/27/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 70387R502

1

Names of Reporting Persons

Tasso Partners, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 912,996.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 912,996.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

912,996.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

14.3 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 70387R502

1

Names of Reporting Persons

Dana Carrera

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 914,246.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 914,246.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

914,246.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

14.3 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PAVmed Inc.
(b)	Address of issuer's principal executive offices: 360 MADISON AVENUE, 360 MADISON AVENUE, NEW YORK, NEW YORK, 10017.
Item 2.
(a)	Name of person filing: This amended Schedule 13G is filed by Tasso Partners, LLC ("Tasso Partners") and Dana Carrera ("Ms. Carrera," and together with Tasso Partners, the "Reporting Persons"). Ms. Carrera controls Tasso Capital, LLC, which in turn controls Tasso Partners. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 99.1 to the initial Schedule 13G, pursuant to which such Reporting Persons have agreed to file the Schedule 13G and all amendments thereto jointly in accordance with the provisions of Rule 13d-1(k) of the Act. Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The filing of this Schedule 13G should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the shares of Common Stock reported herein.
(b)	Address or principal business office or, if none, residence: The principal business address of each of the Reporting Persons is: P.O. Box 503, Rumson, NJ 07760.
(c)	Citizenship: Tasso Partners is a limited liability company formed under the laws of Delaware. Ms. Carrera is a citizen of the United States.
(d)	Title of class of securities: Common Stock, Par Value $0.001 Per Share
(e)	CUSIP No.:
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Tasso Partners beneficially owns 912,996 shares of common stock. Ms. Carrera may be deemed to beneficially own the shares of common stock held by Tasso Partners, because Ms. Carrera indirectly controls Tasso Partners. Ms. Carrera beneficially owns an additional 1,250 shares of common stock.
(b)	Percent of class: Tasso Partners and Ms. Carrera beneficially own 14.3% of the outstanding shares of common stock. The percentage of beneficial ownership is calculated based on 6,383,089 shares of common stock outstanding as of March 27, 2026, as set forth in the Company's annual report on Form 10-K filed on March 27, 2026.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Tasso Partners: 912,996 Ms. Carrera: 914,246
	(ii) Shared power to vote or to direct the vote: Tasso Partners: 0 Ms. Carrera: 0
	(iii) Sole power to dispose or to direct the disposition of: Tasso Partners: 912,996 Ms. Carrera: 914,246
	(iv) Shared power to dispose or to direct the disposition of: Tasso Partners: 0 Ms. Carrera: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Tasso Partners, LLC

Signature:	/s/ Dana Carrera
Name/Title:	Dana Carrera, Manager of Tasso Capital, LLC, which controls Tasso Partners, LLC
Date:	04/03/2026

Dana Carrera

Signature:	/s/ Dana Carrera
Name/Title:	Dana Carrera
Date:	04/03/2026